The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124200922 12420092 2 F 20160420 20160714 20160531 20160719 EXP CA-OTSUKA-2016_009641 OTSUKA 59.07 YR M Y 70.00000 KG 20160719 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124200922 12420092 1 PS ABILIFY MAINTENA ARIPIPRAZOLE 1 Intramuscular 400 MG, QM Y 202971 400 MG SUSPENSION FOR INJECTION /month
124200922 12420092 2 SS ABILIFY MAINTENA ARIPIPRAZOLE 1 Intramuscular 400 MG, QM Y 202971 400 MG SUSPENSION FOR INJECTION /month
124200922 12420092 3 SS ABILIFY MAINTENA ARIPIPRAZOLE 1 Intramuscular 400 MG, QM Y 202971 400 MG SUSPENSION FOR INJECTION /month
124200922 12420092 4 SS ABILIFY MAINTENA ARIPIPRAZOLE 1 Intramuscular 400 MG, QM Y 202971 400 MG SUSPENSION FOR INJECTION /month
124200922 12420092 5 SS ABILIFY MAINTENA ARIPIPRAZOLE 1 Intramuscular 400 MG, QM Y 202971 400 MG SUSPENSION FOR INJECTION /month
124200922 12420092 6 SS ABILIFY MAINTENA ARIPIPRAZOLE 1 Intramuscular 400 MG, QM Y 202971 400 MG SUSPENSION FOR INJECTION /month
124200922 12420092 7 SS ABILIFY MAINTENA ARIPIPRAZOLE 1 Intramuscular 400 MG, QM Y 202971 400 MG SUSPENSION FOR INJECTION /month
124200922 12420092 8 C APO-DIAZEPAM 2 Unknown 3 DF, QD (TAKE 3 TABLETS ONCE DAILY AT BEDTIME) 0 3 DF QD
124200922 12420092 9 C APO-DIAZEPAM 2 Unknown 3 DF, QD 0 3 DF QD
124200922 12420092 10 C APO-DIAZEPAM 2 Unknown 1 DF, UNK 0 1 DF
124200922 12420092 11 C RATIO-CODEINE 2 Unknown 4 DF, QD ()TAKE 2 TABLET TWICE DAILY) 0 4 DF QD
124200922 12420092 12 C FLAMAZINE SILVER SULFADIAZINE 1 Unknown 50 G FOR 15 DAYS (APPLY TO AFFECTED AREA ONLY) 0 50 G
124200922 12420092 13 C CODEIN CODEINE 1 Unknown UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124200922 12420092 1 Paranoia
124200922 12420092 8 Product used for unknown indication
124200922 12420092 11 Product used for unknown indication
124200922 12420092 12 Product used for unknown indication
124200922 12420092 13 Osteoarthritis

Outcome of event

Event ID CASEID OUTC COD
124200922 12420092 OT
124200922 12420092 LT
124200922 12420092 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
124200922 12420092 Acute kidney injury
124200922 12420092 Neuroleptic malignant syndrome
124200922 12420092 Off label use
124200922 12420092 Respiratory failure
124200922 12420092 Rhabdomyolysis
124200922 12420092 Seizure
124200922 12420092 Syncope

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124200922 12420092 1 20151021 0
124200922 12420092 2 20151118 0
124200922 12420092 3 20151216 0
124200922 12420092 4 20160125 0
124200922 12420092 5 20160222 0
124200922 12420092 6 20160322 0
124200922 12420092 7 20160419 0
124200922 12420092 8 20160419 0
124200922 12420092 9 20160412 0
124200922 12420092 10 20160302 0
124200922 12420092 13 1979 0